Application of lncRNA SNP in colorectal cancer susceptibility prediction and prognosis assessment

doi:10.3969/j.issn.1673-8640.2023.12.020

Abstract

Abstract:

Colorectal cancer is one of the most common cancers in the world. Long non-coding RNA（lncRNA） single nucleotide polymorphisms（SNP） play roles in the occurrence and development of colorectal cancer. As a new and less invasive biomarker，lncRNA SNP has a certain value in predicting susceptibility，assessing prognosis，determining pathologic grades and monitoring drug susceptibility of colorectal cancer.

Key words: Long non-coding RNA, Single nucleotide polymorphism, Biomarker, Colorectal cancer

CLC Number:

R446.1

ZHOU Furong, LI Yanzhu, LIU Yonggan. Application of lncRNA SNP in colorectal cancer susceptibility prediction and prognosis assessment[J]. Laboratory Medicine, 2023, 38(12): 1206-1210.

References 46

[1]	LI Y C, CHEN C H, CHANG C L, et al. Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms[J]. Int J Biol Sci, 2021, 17(14):3728-3744. DOI URL
[2]	LI N, LU B, LUO C, et al. Incidence,mortality,survival,risk factor and screening of colorectal cancer:a comparison among China,Europe,and northern America[J]. Cancer Lett, 2021, 522:255-268. DOI URL
[3]	YARLA N S, GALI H, PATHURI G, et al. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention[J]. Semin Cancer Biol, 2019, 56:168-174. DOI PMID
[4]	DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207):1467-1480. DOI PMID
[5]	KEUM N, GIOVANNUCCI E. Global burden of colorectal cancer:emerging trends,risk factors and prevention strategies[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(12):713-732. DOI
[6]	ABDI E, LATIFI-NAVID S, LATIFI-NAVID H. Long noncoding RNA polymorphisms and colorectal cancer risk:progression and future perspectives[J]. Environ Mol Mutagen, 2022, 63(2):98-112. DOI URL
[7]	VILLANUEVA L, ÁLVAREZ-ERRICO D, ESTELLER M. The contribution of epigenetics to cancer immunotherapy[J]. Trends Immunol, 2020, 41(8):676-691. DOI PMID
[8]	LI K, HAN Z, WU J, et al. The relationship between MALAT1 polymorphism rs3200401 C>T and the risk of overall cancer:a meta-analysis[J]. Medicina(Kaunas), 2022, 58(2):176.
[9]	MARCHESE F P, RAIMONDI I, HUARTE M. The multidimensional mechanisms of long noncoding RNA function[J]. Genome Biol, 2017, 18(1):206. DOI PMID
[10]	WEI L, WANG X, LV L, et al. The emerging role of noncoding RNAs in colorectal cancer chemoresistance[J]. Cell Oncol(Dordr), 2019, 42(6):757-768.
[11]	BERMÚDEZ M, AGUILAR-MEDINA M, LIZÁRRAGA-VERDUGO E, et al. LncRNAs as regulators of autophagy and drug resistance in colorectal cancer[J]. Front Oncol, 2019, 9:1008. DOI PMID
[12]	ABDEL-MOTALEB A I, AZZAZY H M, MOUSTAFA A. Toward colorectal cancer biomarkers:the role of genetic variation,wnt pathway,and long noncoding RNAs[J]. OMICS, 2021, 25(5):302-312. DOI URL
[13]	WANG Y, QIU Z, TIAN G, et al. Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population[J]. Sci Rep, 2022, 12(1):2495. DOI PMID
[14]	GAO X, ZHANG S, WANG X. HAND2-AS1 rs2276941 polymorphism affecting the binding of hsa-miR-1275 is associated with the risk of colorectal cancer[J]. DNA Cell Biol, 2022, 41(6):600-605. DOI URL
[15]	YU B, CHEN J, HOU C, et al. LncRNA H19 gene rs2839698 polymorphism is associated with a decreased risk of colorectal cancer in a Chinese Han population:a case-control study[J]. J Clin Lab Anal, 2020, 34(8):e23311. DOI URL
[16]	LI Y, BAO C, GU S, et al. Associations between novel genetic variants in the promoter region of MALAT1 and risk of colorectal cancer[J]. Oncotarget, 2017, 8(54):92604-92614. DOI URL
[17]	SHAKEF O G, SENOUSY M A, ELBAZ E M. Association of rs6983267 at 8q24,HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients[J]. Sci Rep, 2017, 7(1):16246. DOI
[18]	GAO X, YANG J, WANG D, et al. Association between HULC rs7763881 and cancer risk:an updated meta-analysis[J]. Nucleosides Nucleotides Nucleic Acids, 2022, 41(1):85-96. DOI URL
[19]	YE D, HU Y, JING F, et al. A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer[J]. J Hum Genet, 2018, 63(1):47-54. DOI PMID
[20]	YANG M L, HUANG Z, WU L N, et al. LncRNA-PCAT1 rs2632159 polymorphism could be a biomarker for colorectal cancer susceptibility[J]. Biosci Rep, 2019, 39(7):BSR20190708.
[21]	FAN J, XU H, LIU B, et al. Association of a novel antisense lncRNA TP73-AS1 polymorphisms and expression with colorectal cancer susceptibility and prognosis[J]. Genes Genomics, 2022, 44(7):889-897. DOI
[22]	ZHOU L, ZHANG Y, JIN J, et al. Correlation between lncRNA SNHG16 gene polymorphism and its interaction with environmental factors and susceptibility to colorectal cancer[J]. Medicine(Baltimore), 2020, 99(48):e23372.
[23]	QIN W, WANG X, WANG Y, et al. Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer[J]. Cancer Cell Int, 2019, 19:215. DOI
[24]	WU H, HE G, HAN H, et al. Analysis of MIR155HG variants and colorectal cancer susceptibility in Han Chinese population[J]. Mol Genet Genomic Med, 2019, 7(8):e778. DOI URL
[25]	YANG R Q, JIN Z Z, JIANG S Y, et al. LncRNA GAS5 interacts with microRNA-10b to inhibit cell proliferation and migration and induces apoptosis in colorectal cancer[J]. Comput Math Methods Med, 2022, 2022:4996870.
[26]	CAO X, ZHUANG S, HU Y, et al. Associations between polymorphisms of long non-coding RNA MEG3 and risk of colorectal cancer in Chinese[J]. Oncotarget, 2016, 7(14):19054-19059. DOI PMID
[27]	GAO X, LI X, ZHANG S, et al. The association of MEG3 gene rs7158663 polymorphism with cancer susceptibility[J]. Front Oncol, 2021, 11:796774. DOI URL
[28]	YANG X, WU S, LI X, et al. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter[J]. J Clin Lab Anal, 2020, 34(10):e23431. DOI URL
[29]	LV Z, XU Q, SUN L, et al. Four novel polymorphisms in long non-coding RNA HOTTIP are associated with the risk and prognosis of colorectal cancer[J]. Biosci Rep, 2019, 39(5):BSR20180573.
[30]	ZHANG L, MAO J. Long-chain noncoding RNA PVT1 gene polymorphisms are associated with the risk and prognosis of colorectal cancer in the Han Chinese population[J]. Genet Test Mol Biomarkers, 2019, 23(10):728-736. DOI URL
[31]	WU S, SUN H, WANG Y, et al. MALAT 1 rs664589 polymorphism inhibits binding to miR-194-5p,contributing to colorectal cancer risk,growth,and metastasis[J]. Cancer Res, 2019, 79(20):5432-5441. DOI URL
[32]	ALMUTAIRI M, PARINE N R, SHAIK J P, et al. Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population[J]. PLoS One, 2019, 14(9):e0220931.
[33]	ZHENG Y, YANG C, TONG S, et al. Genetic variation of long non-coding RNA TINCR contribute to the susceptibility and progression of colorectal cancer[J]. Oncotarget, 2017, 8(20):33536-33543. DOI PMID
[34]	JIN M, YE D, LI Y, et al. Association of a novel genetic variant in RP11-650L12.2 with risk of colorectal cancer in Han Chinese population[J]. Gene, 2017, 624:21-25. DOI PMID
[35]	JIANG D, JIN M, YE D, et al. Polymorphisms of a novel long non-coding RNA RP11-108K3.2 with colorectal cancer susceptibility and their effects on its expression[J]. Int J Biol Markers, 2020, 35(1):3-9. DOI PMID
[36]	KIM J O, JUN H H, KIM E J, et al. Genetic variants of HOTAIR associated with colorectal cancer susceptibility and mortality[J]. Front Onco, 2020, 10:72.
[37]	YANG Q, ZHENG W, SHEN Z, et al. MicroRNA binding site polymorphisms of the long-chain noncoding RNA MALAT1 are associated with risk and prognosis of colorectal cancer in Chinese Han population[J]. Genet Test Mol Biomarkers, 2020, 24(5):239-248. DOI URL
[38]	GAO X, ZHANG S, WANG X. VPS9D1-AS1 gene rs7206570 polymorphism associated with the clinical stage of colorectal cancer and binding with hsa-miR-361-3p[J]. Hum Cell, 2022, 35(2):522-527. DOI
[39]	ALI M A, SHAKER O G, EZZAT E M, et al. Association between rs1859168/HOTTIP expression level and colorectal cancer and adenomatous polyposis risk in Egyptians[J]. J Interferon Cytokine Res, 2020, 40(6):279-291. DOI URL
[40]	WU S, YANG X, TANG W, et al. Chemotherapeutic risk lncRNA-PVT1 SNP sensitizes metastatic colorectal cancer to FOLFOX regimen[J]. Front Onco, 2022, 12:808889.
[41]	LAMPROPOULOU D I, ARAVANTINOS G, KATIFELIS H, et al. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer[J]. Cancer Biomark, 2019, 25(2):213-221. DOI URL
[42]	SERRATÌ S, DE SUMMA S, PILATO B, et al. Next-generation sequencing:advances and applications in cancer diagnosis[J]. Onco Targets Ther, 2016, 9:7355-7365. DOI URL
[43]	XIAO Z S, ZHAO L, ZHANG X N, et al. Effect of rs67085638 in long non-coding RNA(CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1[J]. J Cell Mol Med, 2021, 25(8):3744-3753. DOI URL
[44]	ZHANG C, WANG Y. KCNQ1OT1 polymorphism rs35622507 and methylation status of KCNQ1OT1 promoter influence the drug resistance to L-OHP[J]. Aging(Albany NY), 2022, 14(4):1836-1847.
[45]	LICHTENSTEIN P, HOLM N V, VERKASALO P K, et al. Environmental and heritable factors in the causation of cancer:analyses of cohorts of twins from Sweden,Denmark,and Finland[J]. N Engl J Med, 2000, 343(2):78-85. DOI URL
[46]	CHO Y A, LEE J, OH J H, et al. Genetic risk score,combined lifestyle factors and risk of colorectal cancer[J]. Cancer Res Treat, 2019, 51(3):1033-1040. DOI URL